Correlation Between Ratnamani Metals and Aarey Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ratnamani Metals and Aarey Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ratnamani Metals and Aarey Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ratnamani Metals Tubes and Aarey Drugs Pharmaceuticals, you can compare the effects of market volatilities on Ratnamani Metals and Aarey Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ratnamani Metals with a short position of Aarey Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ratnamani Metals and Aarey Drugs.

Diversification Opportunities for Ratnamani Metals and Aarey Drugs

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ratnamani and Aarey is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Ratnamani Metals Tubes and Aarey Drugs Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarey Drugs Pharmace and Ratnamani Metals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ratnamani Metals Tubes are associated (or correlated) with Aarey Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarey Drugs Pharmace has no effect on the direction of Ratnamani Metals i.e., Ratnamani Metals and Aarey Drugs go up and down completely randomly.

Pair Corralation between Ratnamani Metals and Aarey Drugs

Assuming the 90 days trading horizon Ratnamani Metals Tubes is expected to under-perform the Aarey Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Ratnamani Metals Tubes is 1.25 times less risky than Aarey Drugs. The stock trades about -0.14 of its potential returns per unit of risk. The Aarey Drugs Pharmaceuticals is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  6,164  in Aarey Drugs Pharmaceuticals on September 2, 2024 and sell it today you would lose (190.00) from holding Aarey Drugs Pharmaceuticals or give up 3.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Ratnamani Metals Tubes  vs.  Aarey Drugs Pharmaceuticals

 Performance 
       Timeline  
Ratnamani Metals Tubes 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ratnamani Metals Tubes has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Aarey Drugs Pharmace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Ratnamani Metals and Aarey Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ratnamani Metals and Aarey Drugs

The main advantage of trading using opposite Ratnamani Metals and Aarey Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ratnamani Metals position performs unexpectedly, Aarey Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarey Drugs will offset losses from the drop in Aarey Drugs' long position.
The idea behind Ratnamani Metals Tubes and Aarey Drugs Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency